Although 295 antihypertensive treatments that were found with impurities were ordered recalled, due to the low risk and specificity of the targeted items, no disruption is expected from the exchange, re-prescriptions, or re-dispensing of such drugs.

The Ministry of Food and Drug Safety announced on the 7th that 295 losartan items that were found to contain azido impurities that exceed the allowed daily intake of 1.5㎍/day (1.7~88.7㎍/day) will be recalled.

However, the ministry emphasized that the risk of its harm to the human body is very low and that the patients should not discontinue taking the drugs. The azido impurities that were detected this time occur specifically in the losarta